Synonyms: LFG-316 | LFG316
Compound class:
Antibody
Comment: Tesidolumab is a fully human monoclonal antibody targeting complement C5. Like eculizumab, this investigational monoclonal inhibits terminal complement activation.
Peptide sequence and secondary structural information for this antibody are available from its IMGT/mAb-DB record. Peptide sequence alignment analysis using the heavy and light variable domains of tesidolumab provide 100% matches to SEQ ID NOs 7 and 8 respectively from patent US8241628 [1]. These peptide sequences correspond to antibody (MOR0)8109 in said patent. |
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
10051 | tesidolumab |
Synonyms ![]() |
LFG-316 | LFG316 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 535 |
Other databases | |
GtoPdb PubChem SID | 252827369 |
Search PubMed clinical trials | tesidolumab |
Search PubMed titles | tesidolumab |
Search PubMed titles/abstracts | tesidolumab |